ArticleACG case reports journal2026
Recurrent Extranodal Diffuse Large B-Cell Lymphoma Manifesting as a Cecal Mass Over 10 Years After Remission.
Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diffuse large B-cell lymphoma (DLBCL) frequently involves extranodal sites, most commonly the gastrointestinal tract; however, predominant colorectal involvement and very late relapse after long-term remission are uncommon. A 70-year-old woman with a history of DLBCL in complete remission for more than 10 years after 6 cycles of R-CHOP presented with progressive weight loss, early satiety, lower abdominal pain, and new-onset urinary urgency and frequency. Cross-sectional imaging revealed a large cecal mass with retroperitoneal extension causing right-sided hydronephrosis. Colonoscopy demonstrated a bulky, ulcerated, partially obstructing mass in the distal ascending colon. Histopathologic evaluation confirmed germinal center B-cell subtype DLBCL with a high proliferation index, and fluorescence in situ hybridization was negative for MYC, BCL2, and BCL6 rearrangements. Bone marrow biopsy showed no evidence of lymphoma, consistent with isolated extranodal relapse. Given frailty, hypoalbuminemia, and prior anthracycline exposure, dose-reduced R-CHOP was initiated with careful limitation of cumulative doxorubicin. This case illustrates a rare presentation of very late, isolated extranodal DLBCL relapse manifesting as a cecal mass with genitourinary obstruction. It underscores the need to consider lymphoma in elderly patients with atypical gastrointestinal and urinary symptoms and highlights the importance of sustained clinical vigilance beyond the conventional 5-year surveillance period in long-term DLBCL survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.